Community Health Systems, Inc. (NYSE: CYH) (the “Company”) today
announced financial and operating results for the three and nine
months ended September 30, 2015.
The operating results of Health Management Associates, Inc.
(“HMA”) are included in the Company’s consolidated results and
statistical data from January 27, 2014, the date the Company
completed its acquisition of HMA. For hospitals acquired in the HMA
merger, same-store operating results and statistical data reflect
the periods from January 1 through September 30, 2015 and 2014, as
if such hospitals were owned during both comparable nine-month
periods. The Company had previously restated its prior period
financial statements and statistical results to reflect the
reclassification in the fourth quarter of 2014 to discontinued
operations for one hospital that was held for sale at December 31,
2014, and was subsequently sold during the nine months ended
September 30, 2015.
Net operating revenues for the three months ended September 30,
2015, totaled $4.846 billion, a 1.4 percent increase compared with
$4.780 billion for the same period in 2014. Income from continuing
operations attributable to Community Health Systems, Inc. common
stockholders decreased to $60 million, or $0.51 per share
(diluted), for the three months ended September 30, 2015, compared
to $61 million, or $0.54 per share (diluted), for the same period
in 2014. The results for the three months ended September 30, 2015,
include $0.05 per share (diluted) related to expenses from the
planned spin-off of Quorum Health Corporation. Excluding this item,
income from continuing operations was $0.56 per share (diluted).
Net income attributable to Community Health Systems, Inc. common
stockholders was $0.44 per share (diluted) for the three months
ended September 30, 2015, compared with $0.54 per share (diluted)
for the same period in 2014. Discontinued operations for the three
months ended September 30, 2015, consisted of $(0.04) per share
(diluted) of losses from operations of entities sold or held for
sale and $(0.03) per share (diluted) of losses on sale, net, for a
total after-tax loss of approximately $(8) million, or $(0.07) per
share (diluted). Weighted-average shares outstanding (diluted) were
116 million for the three months ended September 30, 2015, and 114
million for the three months ended September 30, 2014.
Adjusted EBITDA for the three months ended September 30, 2015,
was $661 million compared with $750 million for the same period in
2014, representing an 11.9 percent decrease.
The consolidated operating results for the three months ended
September 30, 2015, reflect a 1.9 percent decrease in total
admissions, compared with the same period in 2014. Total adjusted
admissions increased 0.2 percent for the three months ended
September 30, 2015, compared with the same period in 2014. On a
same-store basis, admissions decreased 2.1 percent while adjusted
admissions increased 0.1 percent during the three months ended
September 30, 2015, compared with the same period in 2014. On a
same-store basis, net operating revenues increased 1.2 percent
during the three months ended September 30, 2015, compared with the
same period in 2014.
Net operating revenues for the nine months ended September 30,
2015, totaled $14.639 billion, a 6.7 percent increase compared with
$13.721 billion for the same period in 2014. Income from continuing
operations attributable to Community Health Systems, Inc. common
stockholders increased to $268 million, or $2.32 per share
(diluted), for the nine months ended September 30, 2015, compared
to $20 million, or $0.18 per share (diluted), for the same period
in 2014. The results for the nine months ended September 30, 2015,
include $0.09 per share (diluted) of expense related to loss from
early extinguishment of debt, $0.05 per share (diluted) of expense
from fair value adjustments related to HMA legal proceedings,
accounted for at fair value, underlying the CVR agreement, and
related legal expenses, $0.04 per share (diluted) related to
impairment of long-lived assets, $0.01 per share (diluted) of
expenses related to government legal settlements for several qui
tam matters settled in principle and related legal expenses and
$0.05 per share (diluted) related to expenses from the planned
spin-off of Quorum Health Corporation. Excluding these items,
income from continuing operations was $2.55 per share (diluted).
Net income attributable to Community Health Systems, Inc. common
stockholders was $2.08 per share (diluted) for the nine months
ended September 30, 2015, compared with a net loss of $(0.07) per
share (diluted) for the same period in 2014. Discontinued
operations for the nine months ended September 30, 2015, consisted
of $(0.19) per share (diluted) of losses from operations of
entities sold or held for sale, $(0.01) per share (diluted) of
expenses related to the impairment of long-lived assets held for
sale, and $(0.03) per share (diluted) of losses on sale, net, for a
total after-tax loss of approximately $(27) million, or $(0.24) per
share (diluted). Weighted-average shares outstanding (diluted) were
116 million for the nine months ended September 30, 2015, and 112
million for the nine months ended September 30, 2014.
Adjusted EBITDA for the nine months ended September 30, 2015,
was $2.144 billion compared with $1.993 billion for the same period
in 2014, representing a 7.6 percent increase.
The consolidated operating results for the nine months ended
September 30, 2015, reflect a 3.5 percent increase in total
admissions, and a 5.2 percent increase in total adjusted
admissions, compared with the same period in 2014. On a same-store
basis, admissions decreased 1.3 percent while adjusted admissions
increased 0.8 percent during the nine months ended September 30,
2015, compared with the same period in 2014. On a same-store basis,
net operating revenues increased 2.8 percent during the nine months
ended September 30, 2015, compared with the same period in
2014.
Adjusted EBITDA is EBITDA adjusted to exclude discontinued
operations, loss from early extinguishment of debt, impairment of
long-lived assets, net income attributable to noncontrolling
interests, acquisition and integration expenses from the
acquisition of HMA, expenses incurred related to the planned
spin-off of Quorum Health Corporation, expense related to
government legal settlements and related costs, and expense from
fair value adjustments related to the HMA legal proceedings,
accounted for at fair value, underlying the CVR agreement, and
related legal expenses. For information regarding why the Company
believes Adjusted EBITDA presents useful information to investors,
and for a reconciliation of Adjusted EBITDA to net cash provided by
operating activities, see footnote (f) to the Financial Highlights,
Financial Statements and Selected Operating Data below.
Commenting on the results, Wayne T. Smith, chairman and chief
executive officer of Community Health Systems, Inc., said, “Our
financial and operating results for the third quarter of 2015 fell
short of expectations and were affected by a number of factors,
including volume weakness, an unfavorable shift in payor mix, and
higher operating expenses, especially in some of the former HMA
hospitals. Our management team is confronting these challenges by
engaging in a rigorous review of our opportunities and implementing
action plans to drive immediate improvements and long-term growth.
We are especially focused on fundamental operating strategies,
including volume initiatives, expense management, productive
investments and physician recruitment.”
Smith added, “We also believe our previously announced plan to
spin off 38 of our affiliated hospitals into Quorum Health
Corporation will further refine our operating focus on both our
core markets and regional networks where we believe we have the
greatest potential to leverage growth opportunities.”
Included on pages 15, 16, 17 and 18 of this press release is the
Company’s updated 2015 annual earnings guidance. The 2015 guidance
is based on the Company’s historical operating performance, current
trends and other assumptions that the Company believes are
reasonable at this time.
Community Health Systems, Inc. is one of the largest
publicly-traded hospital companies in the United States and a
leading operator of general acute care hospitals in communities
across the country. Through its subsidiaries, the Company currently
owns, leases or operates 198 affiliated hospitals in 29 states with
an aggregate of approximately 30,000 licensed beds.
The Company has announced plans for a spin-off transaction to
create a new, publicly-traded company, Quorum Health Corporation,
with 38 affiliated hospitals and related outpatient services in 16
states, together with Quorum Health Resources, LLC, a subsidiary
providing management and consulting services to non-affiliated
hospitals. The transaction is expected to close during the first
quarter of 2016.
The Company’s headquarters are located in Franklin, Tennessee, a
suburb south of Nashville. Shares in Community Health Systems, Inc.
are traded on the New York Stock Exchange under the symbol “CYH.”
More information about the Company can be found on its website at
www.chs.net.
Community Health Systems, Inc. will hold a conference call on
Tuesday, November 3, 2015, at 10:00 a.m. Central, 11:00 a.m.
Eastern, to review financial and operating results for the third
quarter ended September 30, 2015. Investors will have the
opportunity to listen to a live internet broadcast of the
conference call by clicking on the Investor Relations link of the
Company’s website at www.chs.net. To listen to the live call,
please go to the website at least fifteen minutes early to
register, download and install any necessary audio software. For
those who cannot listen to the live broadcast, a replay will
be available shortly after the call and will continue to be
available through December 4, 2015. Copies of the Company’s
Current Report on Form 8-K (including this press release) and
conference call slide show will be available on the Company’s
website at www.chs.net.
COMMUNITY HEALTH
SYSTEMS, INC. AND SUBSIDIARIES Financial Highlights
(a)(b)(c)(d)(e) (In millions, except per share amounts)
(Unaudited)
Three Months Ended Nine Months
Ended September 30, September 30, 2015
2014 2015 2014 Net operating revenues $
4,846 $ 4,780 $ 14,639 $ 13,721 Adjusted EBITDA (f) 661 750 2,144
1,993 Income from continuing operations (g), (j) 83 94 335 95
Net income (loss) attributable to
Community Health Systems, Inc. stockholders
52 62 241 (8 )
Basic earnings (loss) per share
attributable to Community Health Systems, Inc. common
stockholders:
Continuing operations (g), (j) $ 0.52 $ 0.55 $ 2.33 $ 0.18
Discontinued operations (0.07 ) 0.00 (0.24 )
(0.25 ) Net income (loss) $ 0.45 $ 0.55 $ 2.09
$ (0.07 )
Diluted earnings (loss) per share
attributable to Community Health Systems, Inc. common
stockholders:
Continuing operations (g), (j), (k) $ 0.51 $ 0.54 $ 2.32 $ 0.18
Discontinued operations (0.07 ) 0.00 (0.24 )
(0.25 ) Net income (loss) (k) $ 0.44 $ 0.54 $ 2.08
$ (0.07 )
Weighted-average number of shares outstanding (h): Basic 115 113
115 111 Diluted 116 114 116 112 Net cash provided by
operating activities $ 111 $ 126 $ 615 $ 639
____
For footnotes, see pages 12, 13 and
14.
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES Condensed Consolidated
Statements of Income (a)(b)(c)(d)(e) (In millions, except per
share amounts) (Unaudited)
Three Months Ended September
30, 2015 2014 Amount
% of Net
Operating
Revenues
Amount
% of Net
Operating
Revenues
Operating revenues (net of contractual allowances and discounts) $
5,580 $ 5,538 Provision for bad debts 734
758 Net operating revenues
4,846 100.0 % 4,780 100.0
% Operating costs and expenses: Salaries and benefits 2,240
46.2 % 2,184 45.7 % Supplies 762 15.7 % 730 15.3 % Other operating
expenses 1,144 23.7 % 1,118 23.4 % Government settlement and
related costs (l) - - % 77 1.6 % Electronic health records
incentive reimbursement (54 ) (1.1 ) % (88 ) (1.8 ) % Rent 115 2.4
% 110 2.3 % Depreciation and amortization 288 5.9
% 279 5.8 % Total operating costs and
expenses 4,495 92.8 % 4,410 92.3
% Income from operations (g), (j) 351 7.2 % 370 7.7 %
Interest expense, net 242 4.9 % 249 5.2 % Equity in earnings of
unconsolidated affiliates (12 ) (0.2 ) % (12 ) (0.3 )
%
Income from continuing operations before
income taxes
121 2.5 % 133 2.8 % Provision for income taxes 38 0.8
% 39 0.8 % Income from continuing
operations (g), (j) 83 1.7 % 94
2.0 % Discontinued operations, net of taxes: (Loss)
income from operations of entities sold or held for sale (5 ) (0.1
) % 1 - % Loss on sale, net (3 ) (0.1 ) % - -
% (Loss) income from discontinued operations, net of taxes
(8 ) (0.2 ) % 1 0.0 % Net income 75 1.5
% 95 2.0 % Less: Net income attributable to noncontrolling
interests 23 0.4 % 33 0.7
% Net income attributable to Community Health Systems, Inc.
stockholders $ 52 1.1 % $ 62 1.3 %
Basic earnings (loss) per share
attributable to Community Health Systems, Inc. common
stockholders:
Continuing operations (g), (j) $ 0.52 $ 0.55 Discontinued
operations (0.07 ) 0.00 Net income $ 0.45
$ 0.55
Diluted earnings (loss) per share
attributable to Community Health Systems, Inc. common
stockholders:
Continuing operations (g), (j), (k) $ 0.51 $ 0.54 Discontinued
operations (0.07 ) 0.00 Net income (k) $ 0.44
$ 0.54
Weighted-average number of shares
outstanding (h):
Basic 115 113 Diluted 116
114
____
For footnotes, see pages 12, 13 and
14.
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES Condensed Consolidated
Statements of Income (Loss) (a)(b)(c)(d)(e) (In millions,
except per share amounts) (Unaudited)
Nine Months Ended
September 30, 2015 2014 Amount
% of Net
Operating
Revenues
Amount
% of Net
Operating
Revenues
Operating revenues (net of contractual allowances and discounts) $
16,840 $ 15,920 Provision for bad debts 2,201
2,199 Net operating revenues
14,639 100.0 % 13,721 100.0
% Operating costs and expenses: Salaries and benefits
6,714 45.9 % 6,397 46.6 % Supplies 2,274 15.5 % 2,098 15.3 % Other
operating expenses 3,370 23.0 % 3,251 23.7 % Government settlement
and related costs (l) 1 0.0 % 77 0.6 % Electronic health records
incentive reimbursement (135 ) (0.9 ) % (212 ) (1.5 ) % Rent 344
2.3 % 319 2.3 % Depreciation and amortization 875 6.0 % 815 5.9 %
Amortization of software to be abandoned (j) - -
% 75 0.5 % Total operating costs and
expenses 13,443 91.8 % 12,820
93.4 % Income from operations (g), (j) 1,196 8.2 %
901 6.6 % Interest expense, net 723 5.0 % 728 5.4 % Loss from early
extinguishment of debt 16 0.1 % 73 0.5 % Equity in earnings of
unconsolidated affiliates (51 ) (0.3 ) % (35 ) (0.3 ) % Impairment
of long-lived assets (j) 6 0.0 % 24
0.2 %
Income from continuing operations before
income taxes
502 3.4 % 111 0.8 % Provision for income taxes 167
1.1 % 16 0.1 % Income from continuing
operations (g), (j) 335 2.3 % 95
0.7 % Discontinued operations, net of taxes: Loss
from operations of entities sold or held for sale (22 ) (0.2 ) % (5
) - % Impairment of hospitals sold or held for sale (2 ) - % (23 )
(0.2 ) % Loss on sale, net (3 ) - % - -
% Loss from discontinued operations, net of taxes (27
) (0.2 ) % (28 ) (0.2 ) % Net income 308 2.1 % 67 0.5 %
Less: Net income attributable to noncontrolling interests 67
0.5 % 75 0.6 % Net income (loss)
attributable to Community Health Systems, Inc. stockholders $ 241
1.6 % $ (8 ) (0.1 ) %
Basic earnings (loss) per share
attributable to Community Health Systems, Inc. common
stockholders:
Continuing operations (g), (j) $ 2.33 $ 0.18 Discontinued
operations (0.24 ) (0.25 ) Net income (loss) $ 2.09
$ (0.07 )
Diluted earnings (loss) per share
attributable to Community Health Systems, Inc. common
stockholders:
Continuing operations (g), (j), (k) $ 2.32 $ 0.18 Discontinued
operations (0.24 ) (0.25 ) Net income (loss) (k) $
2.08 $ (0.07 )
Weighted-average number of shares
outstanding (h):
Basic 115 111 Diluted 116
112
____
For footnotes, see pages 12, 13 and
14.
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES Condensed Consolidated
Statements of Comprehensive Income (c) (In millions)
(Unaudited)
Three Months Ended Nine Months
Ended September 30, September 30, 2015
2014 2015 2014 Net income $ 75 $ 95 $
308 $ 67 Other comprehensive (loss) income, net of income taxes:
Net change in fair value of interest rate swaps, net of tax (21 )
11 (22 ) 20 Net change in fair value of available-for-sale
securities, net of tax (9 ) (5 ) (10 ) (2 )
Amortization and recognition of
unrecognized pension cost components, net of tax
1 1 2 1
Other comprehensive (loss) income (29 ) 7
(30 ) 19 Comprehensive income 46 102 278 86
Less: Comprehensive income attributable to noncontrolling interests
23 33 67 75
Comprehensive income attributable to
Community Health Systems, Inc. stockholders
$ 23 $ 69 $ 211 $ 11
____
For footnotes, see pages 12, 13 and
14.
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES Selected
Operating Data (a)(d) (Dollars in millions) (Unaudited)
Three Months Ended September 30, Consolidated
Same-Store 2015 2014 % Change
2015 2014 % Change Number of hospitals (at end
of period) 195 195 193 193 Licensed beds (at end of period) 30,019
29,922 29,715 29,746 Beds in service (at end of period) 26,309
26,669 26,105 26,577 Admissions 230,510 235,009 -1.9 % 229,679
234,576 -2.1 % Adjusted admissions 512,465 511,268 0.2 % 510,330
509,702 0.1 % Patient days 1,003,025 1,023,191 998,575 1,021,919
Average length of stay (days) 4.4 4.4 4.3 4.4 Occupancy rate
(average beds in service) 41.6 % 42.1 % 41.6 % 42.2 % Net operating
revenues $ 4,846 $ 4,780 1.4 % $ 4,824 $ 4,769 1.2 %
Net inpatient revenues as a % of net
patient revenues before provision for bad debts
41.7 % 43.3 % 41.7 % 43.3 %
Net outpatient revenues as a % of net
patient revenues before provision for bad debts
58.3 % 56.7 % 58.3 % 56.7 % Income from operations (g), (j) $ 351 $
370 -5.1 %
Income from operations as a % of net
operating revenues
7.2 % 7.7 % Depreciation and amortization $ 288 $ 279 Equity in
earnings of unconsolidated affiliates $ (12 ) $ (12 ) Liquidity
Data: Adjusted EBITDA (f) $ 661 $ 750 -11.9 %
Adjusted EBITDA as a % of net operating
revenues
13.6 % 15.7 % Net cash provided by operating activities $ 111 $ 126
Net cash provided by operating activities
as a % of net operating revenues
2.3 % 2.6 %
____
For footnotes, see pages 12, 13 and
14.
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES Selected
Operating Data (a)(d)(i) (Dollars in millions) (Unaudited)
Nine Months Ended September 30, Consolidated
Same-Store (1) 2015 2014 % Change
2015 2014 % Change Number of hospitals (at end
of period) 195 195 193 193 Licensed beds (at end of period) 30,019
29,922 29,715 29,746 Beds in service (at end of period) 26,309
26,669 26,105 26,577 Admissions 710,042 685,817 3.5 % 699,146
708,403 -1.3 % Adjusted admissions 1,533,763 1,457,740 5.2 %
1,511,635 1,499,856 0.8 % Patient days 3,163,346 3,044,929
3,108,172 3,150,653 Average length of stay (days) 4.5 4.4 4.4 4.4
Occupancy rate (average beds in service) 43.9 % 44.3 % 43.7 % 44.0
% Net operating revenues $ 14,639 $ 13,721 6.7 % $ 14,469 $ 14,071
2.8 %
Net inpatient revenues as a % of net
patient revenues before provision for bad debts
42.8 % 44.0 % 42.7 % 44.2 %
Net outpatient revenues as a % of net
patient revenues before provision for bad debts
57.2 % 56.0 % 57.3 % 55.8 % Income from operations (g), (j) $ 1,196
$ 901 32.7 %
Income from operations as a % of net
operating revenues
8.2 % 6.6 % Depreciation and amortization $ 875 $ 890 Equity in
earnings of unconsolidated affiliates $ (51 ) $ (35 ) Liquidity
Data: Adjusted EBITDA (f) $ 2,144 $ 1,993 7.6 %
Adjusted EBITDA as a % of net operating
revenues
14.6 % 14.5 % Net cash provided by operating activities $ 615 $ 639
Net cash provided by operating activities
as a % of net operating revenues
4.2 % 4.7 %
(1)
For hospitals acquired in the HMA merger,
same-store operating results and statistical data reflect the
periods from January 1 through September 30, 2015 and 2014, as if
such hospitals were owned during both comparable periods.
____
For footnotes, see pages 12, 13 and
14.
COMMUNITY HEALTH SYSTEMS, INC. AND
SUBSIDIARIES Condensed Consolidated Balance Sheets (b)
(In millions, except share data) (Unaudited)
September
30, 2015 December 31, 2014 ASSETS Current assets
Cash and cash equivalents $ 186 $ 509
Patient accounts receivable, net of
allowance for doubtful accounts of $3,825 and $3,504 at September
30, 2015 and December 31, 2014, respectively
3,686 3,409 Supplies 572 557 Prepaid income taxes - 30 Deferred
income taxes 345 341 Prepaid expenses and taxes 215 192
Other current assets (including assets of
hospitals held for sale of $5 and $38 at September 30, 2015 and
December 31, 2014, respectively)
548 528 Total current assets
5,552 5,566 Property and equipment, gross
14,688 14,264 Less accumulated depreciation and amortization
(4,624 ) (4,095 ) Property and equipment, net 10,064
10,169 Goodwill 8,972
8,951
Other assets, net (including assets of
hospitals held for sale of $32 and $90 at September 30, 2015 and
December 31, 2014, respectively)
2,601 2,735 Total assets $ 27,189
$ 27,421
LIABILITIES AND EQUITY Current
liabilities Current maturities of long-term debt $ 240 $ 235
Accounts payable 1,214 1,293 Income tax payable 102 - Deferred
income taxes 23 23 Accrued interest 163 227
Accrued liabilities (including liabilities
of hospitals held for sale of $1 and $10 at September 30, 2015 and
December 31, 2014, respectively)
1,412 1,811 Total current liabilities
3,154 3,589 Long-term debt
16,647 16,681 Deferred income taxes 847
845 Other long-term liabilities 1,696
1,692 Total liabilities 22,344
22,807 Redeemable noncontrolling interests in equity
of consolidated subsidiaries 522 531
EQUITY Community Health Systems, Inc. stockholders’ equity:
Preferred stock, $.01 par value per share, 100,000,000 shares
authorized; none issued - -
Common stock, $.01 par value per share,
300,000,000 shares authorized; 119,158,604 shares issued and
118,183,055 shares outstanding at September 30, 2015, and
117,701,087 shares issued and 116,725,538 shares outstanding at
December 31, 2014
1 1 Additional paid-in capital 2,122 2,095 Treasury stock, at cost,
975,549 shares at September 30, 2015 and December 31, 2014 (7 ) (7
) Accumulated other comprehensive loss (93 ) (63 ) Retained
earnings 2,218 1,977 Total Community
Health Systems, Inc. stockholders’ equity 4,241 4,003
Noncontrolling interests in equity of consolidated subsidiaries
82 80 Total equity 4,323
4,083 Total liabilities and equity $ 27,189 $
27,421
____
For footnotes, see pages 12, 13 and
14.
COMMUNITY HEALTH SYSTEMS,
INC. AND SUBSIDIARIES Condensed Consolidated Statements of
Cash Flows (b) (In millions) (Unaudited)
Nine Months
Ended September 30, 2015 2014 Cash
flows from operating activities Net income $ 308 $ 67 Adjustments
to reconcile net income to net cash provided by operating
activities: Depreciation and amortization 876 897 Government
settlement and related costs (l) 1 77 Stock-based compensation
expense 44 36 Loss on sale, net 4 - Impairment of long-lived assets
and hospitals sold or held for sale 8 46 Loss from early
extinguishment of debt 16 73 Excess tax benefit relating to
stock-based compensation - (4 ) Other non-cash expenses, net 22 34
Changes in operating assets and liabilities, net of effects of
acquisitions and divestitures: Patient accounts receivable (291 )
(299 ) Supplies, prepaid expenses and other current assets (72 )
(39 ) Accounts payable, accrued liabilities and income taxes (239 )
(189 ) Other (62 ) (60 ) Net cash provided by
operating activities 615 639
Cash flows from investing activities Acquisitions of facilities and
other related equipment (41 ) (3,041 ) Purchases of property and
equipment (696 ) (560 ) Proceeds from disposition of hospitals and
other ancillary operations 87 12 Proceeds from sale of property and
equipment 13 40 Purchases of available-for-sale securities (127 )
(198 ) Proceeds from sales of available-for-sale securities 123 191
Increase in other investments (136 ) (387 ) Net cash
used in investing activities (777 ) (3,943 )
Cash flows from financing activities Proceeds from exercise of
stock options 24 42 Repurchase of restricted stock shares for
payroll tax withholding requirements (20 ) (11 ) Deferred financing
costs and other debt-related costs (30 ) (272 ) Excess tax benefit
relating to stock-based compensation - 4 Proceeds from
noncontrolling investors in joint ventures - 10 Redemption of
noncontrolling investments in joint ventures (18 ) (8 )
Distributions to noncontrolling investors in joint ventures (69 )
(74 ) Borrowings under credit agreements 3,464 8,348 Issuance of
long-term debt - 4,000 Proceeds from receivables facility 112 204
Repayments of long-term indebtedness (3,624 ) (9,091
) Net cash (used in) provided by financing activities (161 )
3,152 Net change in cash and cash equivalents
(323 ) (152 ) Cash and cash equivalents at beginning of period
509 373 Cash and cash equivalents at
end of period $ 186 $ 221
____
For footnotes, see pages 12, 13 and
14.
Footnotes to Financial Highlights,
Financial Statements and Selected Operating Data
(a)
Continuing operating results exclude
discontinued operations for the three and nine months ended
September 30, 2015 and 2014. Both financial and statistical results
exclude entities in discontinued operations for all periods
presented.
(b)
The contingent value right (“CVR”)
entitles the holder to receive a cash payment up to $1.00 per CVR
(subject to downward adjustment but not below zero), subject to the
final resolution of certain legal matters pertaining to HMA, as
defined in the CVR agreement. If the aggregate amount of applicable
losses under the CVR agreement exceeds a deductible of $18 million,
then the amount payable in respect of each CVR shall be reduced
(but not below zero) by an amount equal to the quotient obtained by
dividing: (a) the product of (i) all losses in excess of the
deductible and (ii) 90%; by (b) the number of CVRs outstanding on
the date on which final resolution of the existing litigation
occurs. Since the HMA acquisition date of January 27, 2014,
approximately $28 million in costs have been incurred and
approximately $28 million of settlements have been paid related to
certain HMA legal matters, which collectively exceed the deductible
of $18 million under the CVR agreement. The Company previously
recorded an estimated fair value of the remaining underlying claims
that will be covered by the CVR of $284 million as part of the
acquisition accounting for HMA, which has been adjusted to its
estimated fair value of $263 million at September 30, 2015. In
addition, although future legal fees (which are expensed as
incurred) associated with the HMA legal matters have not been
accrued or included in the table below, such legal fees are taken
into account in determining the total amount of reductions applied
to the amounts owed to CVR holders.
The following table presents the impact of
the recorded amounts as described above as applied to the CVR and
the $18 million deductible and 10% co-insurance amounts (in
millions):
As of September 30, 2015
Legal and other related costs incurred to date $ 28 Settlements 28
Estimated liability for probable contingencies - Estimated
liability for unresolved contingencies at fair value 263
Costs incurred plus certain estimated
liabilities for CVR-related matters
319 Less: CHS deductible of $18 million (18 ) CHS co-insurance at
10% (30 )
Impact of recorded amounts under CVR
agreement after giving effect to deductible and co-insurance
$ 271 CVRs outstanding 265
(c)
The effective date of the HMA acquisition
was January 27, 2014.
(d)
Included in discontinued operations for
the three and nine months ended September 30, 2015, is one hospital
that was required by the Federal Trade Commission to be divested as
part of its approval of the HMA acquisition, and this hospital was
sold on March 1, 2015. Management is actively marketing other
smaller hospitals included as held for sale at September 30, 2015.
In addition, the Company sold several smaller hospitals during the
nine months ended September 30, 2015. The after-tax loss for the
sold or held for sale hospitals, including an impairment charge on
certain long-lived assets sold or held for sale, is approximately
$8 million and $27 million for the three and nine months ended
September 30, 2015, respectively.
(e)
The following table provides information
needed to calculate income per share, which is adjusted for income
attributable to noncontrolling interests (in millions):
Three Months Ended
Nine Months Ended September 30, September 30,
2015 2014 2015 2014
Income from continuing operations
attributable to Community Health Systems, Inc. common
stockholders:
Income from continuing operations, net of taxes $ 83 $ 94 $ 335 $
95
Less: Income from continuing operations
attributable to noncontrolling interests
23 33 67 75
Income from continuing operations
attributable to Community Health Systems, Inc. common stockholders
— basic and diluted
$ 60 $ 61 $ 268 $ 20
(Loss) income from discontinued operations
attributable to Community Health Systems, Inc. common
stockholders:
(Loss) income from discontinued operations, net of taxes $ (8 ) $ 1
$ (27 ) $ (28 )
Less: Loss from discontinued operations
attributable to noncontrolling interests
- - - -
(Loss) income from discontinued operations
attributable to Community Health Systems, Inc. common stockholders
— basic and diluted
$ (8 ) $ 1 $ (27 ) $ (28 )
(f)
EBITDA is a non-GAAP financial measure
which consists of net income attributable to Community Health
Systems, Inc. before interest, income taxes, and depreciation and
amortization. Adjusted EBITDA is EBITDA adjusted to exclude
discontinued operations, loss from early extinguishment of debt,
impairment of long-lived assets, net income attributable to
noncontrolling interests, acquisition and integration expenses from
the acquisition of HMA, expenses incurred related to the planned
spin-off of Quorum Health Corporation, expense related to
government legal settlements and related costs, and expense from
fair value adjustments related to the HMA legal proceedings,
accounted for at fair value, underlying the CVR agreement, and
related legal expenses. The Company has from time to time sold
noncontrolling interests in certain of its subsidiaries or acquired
subsidiaries with existing noncontrolling interest ownership
positions. The Company believes that it is useful to present
Adjusted EBITDA because it excludes the portion of EBITDA
attributable to these third-party interests and clarifies for
investors the Company’s portion of EBITDA generated by continuing
operations. The Company uses Adjusted EBITDA as a measure of
liquidity. The Company has also presented Adjusted EBITDA in this
release because it believes it provides investors with additional
information about the Company’s ability to incur and service debt
and make capital expenditures. Adjusted EBITDA also aligns with a
similar metric as defined in the Company’s senior secured credit
facility, which is a key component in the determination of the
Company’s compliance with some of the covenants under the Company’s
senior secured credit facility, and is used to determine the
interest rate and commitment fee payable under the senior secured
credit facility.
Adjusted EBITDA is not a measurement of
financial performance or liquidity under U.S. GAAP. It should not
be considered in isolation or as a substitute for net income,
operating income, cash flows from operating, investing or financing
activities or any other measure calculated in accordance with U.S.
GAAP. The items excluded from Adjusted EBITDA are significant
components in understanding and evaluating financial performance
and liquidity. This calculation of Adjusted EBITDA may not be
comparable to similarly titled measures reported by other
companies.
The following table reconciles Adjusted
EBITDA, as defined, to net cash provided by operating activities as
derived directly from the condensed consolidated financial
statements (in millions):
Three Months Ended Nine Months Ended
September 30, September 30, 2015 2014
2015 2014 Adjusted EBITDA $ 661 $ 750 $ 2,144 $ 1,993
Interest expense, net (242 ) (249 ) (723 ) (728 ) Provision for
income taxes (38 ) (39 ) (167 ) (16 )
(Loss) income from operations of entities
sold or held for sale, net of taxes
(5 ) 1 (22 ) (5 ) Other non-cash expenses, net 39 26 63 69
Changes in operating assets and
liabilities, net of effects of acquisitions and divestitures
(304 ) (363 ) (680 ) (674 ) Net cash
provided by operating activities $ 111 $ 126 $ 615
$ 639
(g)
Included in non-same-store income from
operations and income from continuing operations are pre-tax
charges related to acquisition costs of $2 million and $7 million
for the three months ended September 30, 2015 and 2014,
respectively, and $6 million and $54 million for the nine months
ended September 30, 2015 and 2014, respectively. These acquisition
costs include expenses related to the acquisition of HMA of $5
million and $44 million for the three and nine months ended
September 30, 2014, respectively.
(h)
The following table sets forth components
reconciling the basic weighted-average number of shares to the
diluted weighted-average number of shares (in millions):
Three Months Ended Nine Months Ended
September 30, September 30, 2015 2014
2015 2014
Weighted-average number of shares
outstanding - basic
115 113 115 111 Add effect of dilutive securities: Stock awards and
options 1 1 1 1
Weighted-average number of shares
outstanding - diluted
116
114 116 112
(i)
For hospitals acquired in the HMA merger,
same-store operating results and statistical data reflect the
periods from January 1 through September 30, 2015 and 2014, as if
such hospitals were owned during both comparable periods.
(j)
Income from continuing operations for the
nine months ended September 30, 2015, includes an impairment charge
of approximately $6 million related to the allocated reporting unit
goodwill for one hospital where a definitive agreement to sell the
hospital was entered into during the quarter ended June 30, 2015.
Included in income from continuing operations for the nine months
ended September 30, 2014, is an impairment charge of approximately
$24 million for internal-use software, and an acceleration of
amortization for the nine months ended September 30, 2014, of
approximately $75 million, to adjust for its shortened remaining
life which ended on July 1, 2014. In connection with the HMA
acquisition, the Company further analyzed its intangible assets
related to internal-use software used in certain of its hospitals
for patient and clinical systems, including software required to
meet criteria for meaningful use attestation and ICD-10 compliance.
This analysis resulted in management reassessing its usage of
certain software products and rationalizing that, with the addition
of the HMA hospitals in the first quarter of 2014, those software
applications were going to be discontinued and replaced with new
applications that better integrate meaningful use and ICD-10
compliance, are more cost effective and can be implemented at a
greater efficiency of scale over future implementations.
(k)
The following supplemental tables
reconcile income from continuing operations and net income
attributable to Community Health Systems, Inc. common stockholders,
as reported, on a per share (diluted) basis, with the adjustments
described herein (total per share amounts may not add due to
rounding):
Three Months Ended Nine Months Ended
September 30, September 30, 2015 2014
2015 2014 (per share - diluted) (per share
- diluted) Income from continuing operations, as
reported $ 0.51 $ 0.54 $ 2.32 $ 0.18 Adjustments: Loss from early
extinguishment of debt - - 0.09 0.40 Amortization of software to be
abandoned - - - 0.42 Impairment of long-lived assets - - 0.04 0.13
Expenses related to the acquisition and integration of HMA - 0.02 -
0.38 Expense from government settlement and related costs - 0.41
0.01 0.42
Expense from fair value adjustments and
legal expenses related to cases covered by the CVR
- 0.04 0.05 0.12
Expenses related to the planned spin-off
of Quorum Health Corporation
0.05 - 0.05 - Income from
continuing operations, excluding adjustments $ 0.56 $ 1.01 $ 2.55 $
2.06
Three Months Ended Nine
Months Ended September 30, September 30,
2015 2014 2015 2014 (per share -
diluted) (per share - diluted) Net income (loss),
as reported $ 0.44 $ 0.54 $ 2.08 $ (0.07 ) Adjustments: Loss from
early extinguishment of debt - - 0.09 0.40 Amortization of software
to be abandoned - - - 0.42 Impairment of long-lived assets - - 0.04
0.13 Expenses related to the acquisition and integration of HMA -
0.02 - 0.38 Expense from government settlement and related costs -
0.41 0.01 0.42
Expense from fair value adjustments and
legal expenses related to cases covered by the CVR
- 0.04 0.05 0.12
Expenses related to the planned spin-off
of Quorum Health Corporation
0.05 - 0.05 - Net income,
excluding adjustments $ 0.49 $ 1.02 $ 2.31 $ 1.81
(l)
The $0.01 per share (diluted) of expense
for “Government settlement and related costs” for the nine months
ended September 30, 2015, is the net impact of several qui tam
lawsuits settled in principle during the nine months ended
September 30, 2015, and related legal expenses.
Regulation FD Disclosure
Set forth below is selected information
concerning the Company’s projected consolidated operating results
for the year ending December 31, 2015. These projections
update selected guidance issued on August 3, 2015, and are based on
the Company’s historical operating performance, current trends and
other assumptions that the Company believes are reasonable at this
time. The 2015 guidance should be considered in conjunction with
the assumptions included herein. See pages 17 and 18 for a list of
factors that could affect the future results of the Company or the
healthcare industry generally.
The following is provided as guidance to
analysts and investors:
2015 Projection Range Net operating revenues less
provision for bad debts (in millions) $ 19,600 to $ 19,800 Adjusted
EBITDA (in millions) $ 2,900 to $ 3,025 Income from continuing
operations per share - diluted $ 3.40 to $ 3.75 Same-store hospital
annual adjusted admissions growth 0.0 % to 1.5 % Weighted-average
diluted shares, in millions, for the fourth quarter and the full
year 115.5 to 116.5
The following assumptions were used in developing the 2015
guidance provided above:
- The Company’s projections exclude the
following:
- Payments related to the CVRs issued in
connection with the HMA acquisition, and changes in the valuation
of liabilities underlying the CVR;
- Losses from the early extinguishment of
debt;
- Impairment of long-lived assets;
- Resolution of government investigations
or other significant legal settlements;
- Costs incurred in connection with the
planned spin-off transaction of Quorum Health Corporation, which
consists of 38 hospitals and Quorum Health Resources, LLC; and
- Other significant gains or losses that
neither relate to the ordinary course of business nor reflect the
Company’s underlying business performance.
- The Company has classified several
small hospitals as held for sale, and the operating results of
these hospitals have been moved to discontinued operations and have
also been excluded from these projections.
- The previously assumed acquisition of
MetroHealth Hospital in Grand Rapids, Michigan, was terminated on
August 3, 2015. The 2015 projections now assume no hospital
acquisitions in 2015.
Other assumptions used in the above guidance:
- Benefits to Adjusted EBITDA from
Healthcare Reform in 2015 of an additional $115 million to $150
million of net operating revenues before government
deductions.
- Achievement of additional acquisition
synergies related to the HMA acquisition of at least an additional
$150 million during 2015.
- Health Information Technology (HITECH)
electronic health records incentive reimbursement of approximately
$155 million to $165 million for the year ended December 31,
2015.
- Continuation and approval of the
California hospital provider fee program for 2015.
- For comparison purposes, 2014 earnings
per share of $3.29, included a benefit from the reversal of a tax
liability of approximately $0.08 per share (diluted) and the
benefit of reduced amortization from the abandonment of software of
$0.09 per share (diluted) which the Company does not anticipate
recurring in 2015.
- The settlement of certain claims
related to the BP oil spill, for which the Company previously
expected to recognize up to $28 million, are no longer expected to
be recognized in 2015.
- Same-store hospital annual adjusted
admissions growth of 0.0% to 1.5% for 2015, which does not take
into account service closures and weather-related or other unusual
events.
- Expressed as a percentage of net
operating revenues, depreciation and amortization of approximately
6.0% to 6.2% for 2015. Additionally, this is a fixed cost and the
percentages may change as revenue varies. Such amounts exclude the
possible impact of any future hospital fixed asset impairments and
acceleration of amortization of software to be abandoned.
- Interest expense, expressed as a
percentage of net operating revenues, of approximately 5.0% to
5.1%; however, interest expense is a fixed cost and percentages may
vary as revenue varies. Total fixed rate debt, including swaps, is
expected to average approximately 60% to 70% of total debt during
2015.
- Expressed as a percentage of net
operating revenues, equity in earnings of unconsolidated affiliates
of approximately 0.2% to 0.3% for 2015.
- Expressed as a percentage of net
operating revenues, net income attributable to noncontrolling
interests of approximately 0.5% to 0.6% for 2015.
- Expressed as a percentage of income
from continuing operations before income taxes, provision for
income tax of approximately 32.0% to 34.0% for 2015.
- Capital expenditures are projected as
follows (in millions):
2015 Guidance Total $950 to $1,100
- Net cash provided by operating
activities, excluding cash flows related to the CVR and settlement
of legal contingencies, is projected as follows (in millions):
2015 Guidance Total
$1,500 to $1,650
Cash provided by operating activities in 2015
will be negatively impacted by approximately $300 million,
primarily from a reduction in tax refunds, and the timing of
payroll payments, compared to the adjusted cash flows from
operations of $1.822 billion in 2014.
- Weighted average shares outstanding are
projected to be between approximately 115.5 million to 116.5
million for the fourth quarter and the year ended 2015. Weighted
average shares outstanding have been adjusted to include the
estimated dilutive impact from “in-the-money” stock options and
restricted shares.
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as
amended, and the Private Securities Litigation Reform Act of 1995
that involve risk and uncertainties. All statements in this press
release other than statements of historical fact, including
statements regarding projections, expected operating results, and
other events that depend upon or refer to future events or
conditions or that include words such as “expects,” “anticipates,”
“intends,” “plans,” “believes,” “estimates,” “thinks,” and similar
expressions, are forward-looking statements. Although the Company
believes that these forward-looking statements are based on
reasonable assumptions, these assumptions are inherently subject to
significant economic and competitive uncertainties and
contingencies, which are difficult or impossible to predict
accurately and may be beyond the control of the Company.
Accordingly, the Company cannot give any assurance that its
expectations will in fact occur and cautions that actual results
may differ materially from those in the forward-looking statements.
A number of factors could affect the future results of the Company
or the healthcare industry generally and could cause the Company’s
expected results to differ materially from those expressed in this
press release.
These factors include, among other things:
- general economic and business
conditions, both nationally and in the regions in which we
operate;
- implementation, effect of, and changes
to, adopted and potential federal and state healthcare reform
legislation and other federal, state or local laws or regulations
affecting the healthcare industry;
- the extent to which states support
increases, decreases or changes in Medicaid programs, implement
healthcare exchanges or alter the provision of healthcare to state
residents through regulation or otherwise;
- risks associated with our substantial
indebtedness, leverage, and debt service obligations;
- demographic changes;
- changes in, or the failure to comply
with, governmental regulations;
- potential adverse impact of known and
unknown government investigations, audits, and Federal and State
False Claims Act litigation and other legal proceedings;
- our ability, where appropriate, to
enter into and maintain provider arrangements with payors and the
terms of these arrangements, which may be further impacted by the
consolidation of health insurers and managed care companies;
- changes in, or the failure to comply
with, contract terms with payors and changes in reimbursement rates
paid by federal or state healthcare programs or commercial
payors;
- changes in inpatient or outpatient
Medicare and Medicaid payment levels;
- the effects related to the continued
implementation of the sequestration spending reductions and the
potential for future deficit reduction legislation;
- increases in the amount and risk of
collectability of patient accounts receivable, including the impact
of the implementation of ICD-10;
- the efforts of insurers, healthcare
providers and others to contain healthcare costs, including the
trend toward value-based purchasing;
- our ongoing ability to demonstrate
meaningful use of certified electronic health record technology and
recognize income for the related Medicare or Medicaid incentive
payments;
- increases in wages as a result of
inflation or competition for highly technical positions and rising
supply and drug costs due to market pressure from pharmaceutical
companies and new product releases;
- liabilities and other claims asserted
against us, including self-insured malpractice claims;
- competition;
- our ability to attract and retain, at
reasonable employment costs, qualified personnel, key management,
physicians, nurses and other healthcare workers;
- trends toward treatment of patients in
less acute or specialty healthcare settings, including ambulatory
surgery centers or specialty hospitals;
- changes in medical or other
technology;
- changes in U.S. generally accepted
accounting principles;
- the availability and terms of capital
to fund additional acquisitions or replacement facilities or other
capital expenditures;
- our ability to successfully make
acquisitions or complete divestitures;
- our ability to successfully integrate
any acquired hospitals, including those of HMA, or to recognize
expected synergies from acquisitions;
- the impact of the acquisition of HMA on
third-party relationships;
- the impact of seasonal severe weather
conditions;
- our ability to obtain adequate levels
of general and professional liability insurance;
- timeliness of reimbursement payments
received under government programs;
- effects related to outbreaks of
infectious diseases;
- the impact of the external, criminal
cyber-attack suffered by us in the second quarter of 2014,
including potential reputational damage, the outcome of our
investigation and any potential governmental inquiries, the outcome
of litigation filed against us in connection with this
cyber-attack, the extent of remediation costs and additional
operating or other expenses that we may continue to incur, and the
impact of potential future cyber-attacks or security breaches;
- the timing and completion of the
previously announced planned spin-off;
- the effects of the planned spin-off on
our business, including our ability to achieve the anticipated
benefits of the spin-off; and
- the other risk factors set forth in our
other public filings with the Securities and Exchange Commission,
including our 2014 Form 10-K, filed on February 25, 2015.
The consolidated operating results for the three and nine months
ended September 30, 2015, are not necessarily indicative of the
results that may be experienced for any future periods. The Company
cautions that the projections for calendar year 2015 set forth in
this press release are given as of the date hereof based on
currently available information. The Company undertakes no
obligation to revise or update any forward-looking statements, or
to make any other forward-looking statements, whether as a result
of new information, future events or otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151102006671/en/
Community Health Systems, Inc.W. Larry Cash,
615-465-7000President of Financial Services and Chief Financial
Officer
Community Health Systems (NYSE:CYH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Community Health Systems (NYSE:CYH)
Historical Stock Chart
From Apr 2023 to Apr 2024